High BAALC expression associates with other molecular prognostic markers, poor outcome and a distinct gene expression signature in cytogenetically normal acute myeloid leukemia (CN AML): A Cancer and Leukemia Group B (CALGB) study

被引：0
|
作者：
Langer, C.
Ruppert, A. S.
Radmacher, M. D.
Whitman, S. P.
Paschka, P.
Baldus, C. D.
Mrozek, K.
Kolitz, J. E.
Marcucci, G.
Bloomfield, C. D.
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Charite Campus Benjamin Franklin, Berlin, Germany
[3] North Shore Univ Hosp, Manhasset, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7013
引用
收藏
页数：2
相关论文
共 50 条
  • [1] High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia:: a Cancer and Leukemia Group B (CALGB) study
    Langer, Christian
    Radmacher, Michael D.
    Ruppert, Amy S.
    Whitman, Susan P.
    Paschka, Peter
    Mrozek, Krzysztof
    Baldus, Claudia D.
    Vukosavljevic, Tamara
    Liu, Chang-Gong
    Ross, Mary E.
    Powell, Bayard L.
    de la Chapelle, Albert
    Kolitz, Jonathan E.
    Larson, Richard A.
    Marcucci, Guido
    Bloomfield, Clara D.
    BLOOD, 2008, 111 (11) : 5371 - 5379
  • [2] MicroRNA (miR) expression signatures in molecular subsets of cytogenetically normal (CN) acute myeloid leukemia (AML): A Cancer and Leukemia Group B (CALGB) study
    Radmacher, M. D.
    Marcucci, G.
    Paschka, P.
    Vukosavljevic, T.
    Whitman, S. P.
    Ruppert, A. S.
    Mrozek, K.
    Kolitz, J. E.
    Larson, R. A.
    Bloomfield, C. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Prognostic impact of BAALC expression in the context of other molecular markers in cytogenetically normal acute myeloid leukemia
    Dohner, Konstanze
    Corbacioglu, Andrea
    Eiwen, Karina
    Ewert, Judith
    Frohling, Stefan
    Bullinger, Lars
    Krauter, Juergen
    Schlegelberger, Brigitte
    Ganser, Arnold
    Dohner, Hartmut
    Schlenk, Richard F.
    BLOOD, 2007, 110 (11) : 1021A - 1021A
  • [4] Aberrant Gene Expression of BAALC and ERG in Older [≥60 Years (y)] De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML): A Cancer and Leukemia Group B (CALGB) Study
    Schwind, Sebastian
    Marcucci, Guido
    Maharry, Kati
    Mrozek, Krzysztof
    Radmacher, Michael D.
    Holland, Kelsi B.
    Becker, Heiko
    Whitman, Susan P.
    Wu, Yue-Zhong
    Baer, Maria R.
    Powell, Bayard L.
    Carroll, Andrew J.
    Caligiuri, Michael A.
    Larson, Richard A.
    Bloomfield, Clara D.
    BLOOD, 2009, 114 (22) : 93 - 94
  • [5] Prognostic impact of NPM1 mutations in cytogenetically normal (CN) acute myeloid leukemia (AML) is adversely affected by high expression of the ERG gene:: A cancer and leukemia group B (CALGB) study
    Paschka, P.
    Marcucci, G.
    Maharry, K.
    Whitman, S. P.
    Ruppert, A. S.
    Vukosavljevic, T.
    Mrozek, K.
    Powell, B. L.
    Kolitz, J. E.
    Larson, R. A.
    Bloomfield, C. D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 145 - 145
  • [6] Gene and microRNA (miRNA) expression signatures and prognostic significance of CEBPA mutations in cytogenetically normal (CN) acute myeloid leukemia (AML)with high-risk molecular features:: A cancer and leukemia group B (CALGB) study
    Marcucci, Guido
    Maharry, Kati
    Radmacher, Michael D.
    Mrozek, Krzysztof
    Vukosavljevic, Tamara
    Paschka, Peter
    Whitman, Susan P.
    Langer, Christian
    Baldus, Claudia D.
    Ruppert, Amy S.
    Powell, Bayard L.
    Carroll, Andrew J.
    Caligiuri, Michael A.
    Kolitz, Jonathan E.
    Larson, Richard A.
    Bloomfield, Clara D.
    BLOOD, 2007, 110 (11) : 39A - 39A
  • [7] Low Meningioma 1 (MN1) gene expression to predict outcome in cytogenetically normal acute myeloid leukemia (CN-AML): A Cancer and Leukemia Group B (CALGB) study
    Langer, C.
    Maharry, K.
    Mrozek, K.
    Paschka, P.
    Whitman, S. P.
    Kolitz, J. E.
    Larson, R. A.
    Marcucci, G.
    Bloomfield, C. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Heritable polymorphism predisposes to high expression of BAALC in cytogenetically normal acute myeloid leukemia (CN-AML)
    Eisfeld, Ann-Kathrin
    Marcucci, Guido
    Liyanarachchi, Sandya
    Doehner, Konstanze
    Schwind, Sebastian
    Maharry, Kati
    Nicolet, Deedra
    Radmacher, Michael D.
    Doehner, Hartmut
    Tanner, Stephan M.
    Bloomfield, Clara D.
    de la Chapelle, Albert
    CANCER RESEARCH, 2012, 72
  • [9] Prognostic significance of BAALC expression in cytogenetically normal acute myeloid leukemia
    Chopra, Anita
    Verma, Deepak
    Kumar, Rajive
    Singh, Jay
    Ali, Shadab
    Bakhshi, Sameer
    Sharma, Atul
    Palanichamy, Jayanth Kumar
    Sharawat, Surender Kumar
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 78 - 79
  • [10] BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
    Schwind, Sebastian
    Marcucci, Guido
    Maharry, Kati
    Radmacher, Michael D.
    Mrozek, Krzysztof
    Holland, Kelsi B.
    Margeson, Dean
    Becker, Heiko
    Whitman, Susan P.
    Wu, Yue-Zhong
    Metzeler, Klaus H.
    Powell, Bayard L.
    Kolitz, Jonathan E.
    Carter, Thomas H.
    Moore, Joseph O.
    Baer, Maria R.
    Carroll, Andrew J.
    Caligiuri, Michael A.
    Larson, Richard A.
    Bloomfield, Clara D.
    BLOOD, 2010, 116 (25) : 5660 - 5669
12345